| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
25,670 |
20,974 |
$1.20M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
30,748 |
26,728 |
$1.01M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
11,083 |
9,324 |
$507K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
6,036 |
4,875 |
$397K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
8,120 |
7,124 |
$303K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
10,395 |
9,278 |
$303K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
13,736 |
6,513 |
$109K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
9,369 |
8,187 |
$71K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
845 |
798 |
$24K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
109 |
73 |
$3K |
| 71046 |
Radiologic examination, chest; 2 views |
139 |
107 |
$1K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
61 |
34 |
$792.14 |
| 93000 |
|
61 |
52 |
$512.44 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
32 |
30 |
$231.12 |
| 81025 |
|
41 |
38 |
$167.14 |
| 99000 |
|
7,893 |
6,630 |
$57.04 |
| 81003 |
|
3,369 |
2,686 |
$31.64 |
| 82962 |
|
24 |
13 |
$22.40 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
50 |
48 |
$2.77 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
13 |
13 |
$2.60 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
13 |
13 |
$1.50 |
| A9150 |
Non-prescription drugs |
277 |
230 |
$1.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
18 |
17 |
$0.36 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
31 |
29 |
$0.00 |